A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses-Reference-Cited by-同舟云学术

A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses

Published:2016-11 Issue:46 Volume:291 Page:23869-23881
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Liu Bai,Kong Lin,Han Kaiping,Hong Hao,Marcus Warren D.,Chen Xiaoyue,Jeng Emily K.,Alter Sarah,Zhu Xiaoyun,Rubinstein Mark P.,Shi Sixiang,Rhode Peter R.,Cai Weibo,Wong Hing C.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference30 articles.

1. Interleukin 15: biology and relevance to human disease;Fehniger;Blood,2001

2. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design;Waldmann;Nat. Rev. Immunol,2006

3. Novel human interleukin-15 agonists;Zhu;J. Immunol,2009

4. IL-15:IL-15 receptor α superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization;Han;Cytokine,2011

5. Efficacy and mechanism-of-action of a novel superagonist interleukin-15:interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma;Xu;Cancer Res,2013

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment;Bioactive Materials;2024-12

2. Cancer immunity by tissue‐resident type 1 innate lymphoid cells and killer innate‐like T cells;Immunological Reviews;2024-03-20

3. Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies;Science Translational Medicine;2024-03-06

4. Interleukin-15 in kidney disease and therapeutics;Current Opinion in Nephrology & Hypertension;2023-12-26

5. The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?;Cancers;2023-12-08